1/8/2023 0 Comments Credit insights![]() ![]() What we see that translates to is a continued robust pipeline of new products going into the FDA and really nice outcomes for patients as we start to address a lot of these disease states that haven't really had great solutions historically. We're really seeing the industry harnessing new technologies, whether that's gene therapy, cell therapy, bispecific antibodies, and harnessing those technologies to really meet unmet need in the industry. I think that those are the things that we'll see come to the market over the next several years.Ĭhris: Heading into 2020, we see really a continuation of some very positive trends that we've seen for the last few years. You might be halfway around the world and the ability to be able to access that. As we think about things like blockchain technology, the ability to be able to take your medical records with you wherever you go. ![]() For example, in oncology, where you can gather information in a short period of time, make that diagnosis from a clinical perspective and really get the patient on the right treatment protocol. They'll look it up, they'll say, "Is there a clinic near me "to be able to get the services that I want?"Īs we think about the future of technology, we think about things like artificial intelligence. So, we think about them getting most of their information from a handheld device. Millennials and Generation X'ers, most of them don't have a primary care doctor today. Three, it's through data analytics where you're sharing that back with the member. It's two, things like Telehealth and Telemedicine reaching that patient where they want to be reached. It's one, making it easier, for example, to check into the physician’s office. So, you're really, as a consumer, thinking about how do I want to spend those dollars? Where am I going to get the best outcome for the lowest cost? When we think about companies using technology to really enhance the consumer experience, it's really across the board. ![]() Today, your out-of-pocket costs on average are north of $2,000. And so, as we think about the disruptions that are happening in the marketplace, we think that drug retails have the opportunity to utilize that footprint that they have today to provide more services. The consumer wants their services where they want them, when they want them, at the lowest price. Bancorp Investments Order Processing information.Lisa: The consumer's the biggest disruptor in healthcare. An investor brochure describing BrokerCheck is also available through FINRA. To request such information, contact FINRA toll-free at 800.289.9999 or via. The Financial Industry Regulatory Authority (FINRA) Rule 2267 provides for BrokerCheck to allow investors to learn about the professional background, business practices, and conduct of FINRA member firms or their brokers. Bancorp Investments Statement of Financial Condition is available for you to review, print and download. Bancorp Investments must provide clients with certain financial information. Pursuant to the Securities Exchange Act of 1934, U.S. Products may not be available in all states. Bancorp subsidiaries and affiliates of U.S. Insurance products are available through various affiliated non-bank insurance agencies, which are U.S. To understand how brokerage and investment advisory services and fees differ, the Client Relationship Summary and Regulation Best Interest Disclosure are available for you to review. Bancorp Investments is registered with the Securities and Exchange Commission as both a broker-dealer and an investment adviser. Bancorp Investments, Inc., member FINRA and SIPC, an investment adviser and a brokerage subsidiary of U.S. Bancorp Investments, the marketing name for U.S. Investment and insurance products and services including annuities are available through U.S. You should consult your tax and/or legal advisor for advice and information concerning your particular situation. Your tax and financial situation is unique. Bancorp Investments and their representatives do not provide tax or legal advice. Investors should consult with their investment professional for advice concerning their particular situation. Not a representation or solicitation or an offer to sell/buy any security. Not to be construed to meet the needs of any particular investor. Not for use as a primary basis of investment decisions. It is not intended to provide specific investment advice and should not be construed as an offering of securities or recommendation to invest. Bancorp Investments and is not intended to be a forecast of future events or guarantee of future results. The information provided represents the opinion of U.S. Bancorp Investments is the marketing logo for U.S.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |